Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained release delivery of active agents to treat glaucoma and ocular hypertension

Sustained release delivery of active agents to treat glaucoma and ocular hypertension

US Patent 9610271 · Granted Apr 4, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ophthalmic drug sustained release formulation and uses thereof2024
Lacrimal implants and related methods2024
Lacrimal implants and related methods2023
Lacrimal implants and related methods2023
Static pin insertion tool for lacrimal implant2022
Ophthalmic drug sustained release formulation and uses thereof2022
Photovoltaic-photothermal reaction complementary full-spectrum solar utilization2021
Therapeutic regimens and methods for improving visual function in visual disorde2020
Sustained release delivery of active agents to treat glaucoma and ocular hyperte2020
Sustained release delivery of active agents to treat glaucoma and ocular hyperte2020
Sustained release delivery of active agents to treat glaucoma and ocular hyperte2020
Sustained release delivery of active agents to treat glaucoma and ocular hyperte2020